SCHEMBL22150190

SCHEMBL22150190

C=CC(=O)NCCCCC(=O)Nc1ccc(CN)nc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ HDAC3 O15379 14/20 0.41
▸ HDAC1 Q13547 14/20 0.41
▸ HDAC2 Q92769 14/20 0.41
▸ HDAC6 Q9UBN7 13/20 0.41
▸ HDAC4 P56524 12/20 0.41
▸ HDAC7 Q8WUI4 12/20 0.41
▸ HDAC10 Q969S8 12/20 0.41
▸ HDAC11 Q96DB2 12/20 0.41
▸ HDAC8 Q9BY41 12/20 0.41
▸ HDAC9 Q9UKV0 12/20 0.41
▸ HDAC5 Q9UQL6 12/20 0.41
▸ ZDHHC20 Q5W0Z9 1/20 0.37
▸ ZDHHC2 Q9UIJ5 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ NCOR2 Q9Y618 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22149742 0.99 HDAC3 (0.42) SMN1; SMN2HDAC3HDAC1HDAC2HDAC6
SCHEMBL23810139 0.96 SMN1; SMN2 (0.42) SMN1; SMN2HDAC3HDAC1HDAC2HDAC6
SCHEMBL22150196 0.83 HDAC8 (0.39) SMN1; SMN2HDAC3HDAC1HDAC2HDAC6
SCHEMBL23476624 0.82 SMN1; SMN2 (0.48) SMN1; SMN2HDAC3HDAC1HDAC2HDAC6
SCHEMBL22149736 0.82 HDAC8 (0.40) SMN1; SMN2HDAC3HDAC1HDAC2HDAC6
SCHEMBL22149953 0.81 SMN1; SMN2 (0.45) SMN1; SMN2HDAC3HDAC1HDAC2HDAC6
SCHEMBL22149737 0.80 CA12 (0.38) MEN1KMT2A
SCHEMBL22149955 0.79 SMN1; SMN2 (0.38) SMN1; SMN2HDAC3HDAC1HDAC2HDAC6
SCHEMBL22150633 0.78 KDM4E (0.45) HDAC1ZDHHC20ZDHHC2
SCHEMBL22150873 0.75 GAA (0.41) SMN1; SMN2HDAC3HDAC1HDAC2HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210284609-A1 HETEROCYCLIC AZIDE UNITS AND THEIR USE IN POLYMER COATINGS ILLUMINA CAMBRIDGE LIMITED (GB) 2021-09-16 — — US disclosed
WO-2020126598-A1 HETEROCYCLIC AZIDE UNITS AND THEIR USE IN POLYMER COATINGS ILLUMINA CAMBRIDGE LIMITED (GB) 2020-06-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210284609-A1 HETEROCYCLIC AZIDE UNITS AND THEIR USE IN POLYMER COATINGS POLL, PCNA, DNMT3A SMN1; SMN2 1789/4885HDAC3 3176/4885HDAC1 2349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback